Barclays raised the firm’s price target on Keurig Dr Pepper (KDP) to $39 from $36 and keeps an Overweight rating on the shares. The firm sensed growing concerns about green coffee pressures ...

EverSource Wealth Advisors LLC lessened its holdings in shares of Keurig Dr Pepper Inc. (NASDAQ:KDP – Free Report) by 20.0% ...

In a report released today, Lauren Lieberman from Barclays maintained a Buy rating on Keurig Dr Pepper (KDP – Research Report), with a price target of $36.00. The company’s shares closed ...

Barclays analyst Lauren Liberman said Keurig Dr Pepper’s outlook was “better than feared, with many assuming that green coffee cost inflation would preclude an algorithm guide”. She added ...

Piper Sandler initiated coverage on shares of Keurig Dr Pepper in a research note on Tuesday. They set a “neutral” rating and a $35.00 price objective for the company. Finally, Barclays restat ...

Beverage maker Keurig Dr Pepper Inc. KDP exceeded analyst expectations ... Recent ratings from Barclays, UBS, and TD Cowen average $36.33, suggesting a potential 4.86% upside.

Beverage company Keurig Dr Pepper (NASDAQ:KDP) will be reporting earnings tomorrow morning. Here’s what to expect. Keurig Dr Pepper missed analysts’ revenue expectations by 0.7% last quarter ...

Difficulties noted in U.S. coffee, with sales declining by 2.4% due to pricing issues. Keurig Dr Pepper, known for popular beverages such as Dr Pepper, Snapple, and the Keurig coffee system ...